References
1. https://en.wikisource.org/wiki/The_Marhall_Plan-Speech
2. Marshall J. On the development of the great anterior veins in man and
mammalia: including an account of certain remnants of foetal structure
found in the adult, a comparative view of these great veins in the
different mammalia, and an analysis of their occasional peculiarities in
the human subject. Phil Trans R Soc Lond. 1850;140:1324-1327.
3. Scherlag BJ, Yeh BK, Robinson MJ. Inferior interatrial pathway in the
cog. Circ Res. 1972;31:18-35.
4. Hwang C, Karagueuzian HS, Chen PS. Idiopathic paroxysmal atrial
fibrillation induced by a focal discharge mechanism in the left superior
pulmonary vein: possible roles of the ligament of Marshall. J Cardiovasc
Electrophysiol. 1999;10:636-648.
5. Katritsis D, Joannidis JP, Anagnoustopoulos CE, Sarris GE,
Giazitzoglou E, Korovesis S, Camm AJ. Identification and catheter
ablation of extracardiac and intracardiac components of ligament of
Marshall tissue for treatment of paroxysmal atrial fibrillation. J
Cardiovasc Electrophysiol. 2001;12:750-758.
6. Valderrabano M, Chen HR, Sdhu J, Rao L, Ling Y, Khoury DS. Retrograde
ethanol infusion in the vein of Marshall: regional left atrial ablation,
vagal denervation and feasibility in humans. Circ Arrhyhtm
Electrophysiol. 2009;2:50-56.
7. Derval N, Duchateau J, Denis A, Ramirez FD, Mahida S, Andre C, Krisai
P, Nakatani Y, Kitamura T, Takigawa M, Chauvel R, Tixier R, Pillois X,
Sacher F, Hocini M, Haissaguerre M, Jais P, Pambrun T. Marshall bundle
elimination, Pulmonary vein isolation, and Line completion for
ANatomical ablation of persistent atrial fibrillation (Marshall PLAN):
Prospective, single-center study. Heart Rhythm. 2012;18:529-537.
8. Valderrabano M, Peterson LE, Swarup V, Schurmann PA, Makkar A, Doshi
RN, DeLurgio D, Athill CA, Ellenbogen KA, Natale A, Koneru J, Dave AS,
Giorgberidze I, Afshar H, Guthrie ML, Bunge R, Morillo CA, Kleinman NS.
Effect of catheter ablation with vein of Marshall ethanol infusion vs
catheter ablation alone on persistent atrial fibrillation: the VENUS
randomized clinical trial. JAMA. 2020;324:1620-1628.
9. Kamakura T, Andre C, Duchateau J, Nakashima T, Nakatani Y, Takagi T,
Krisai P, Ascione C, Balbo C, Tixier R, Chauvel R, Cheniti G, Kusano K,
Cochet H, Denis A, Sacher F, Hocini M, Jais P, Haissaguerre M, Derval N,
Pambrun T. Distribution of atrial low voltage induced by vein of
Marshall ethanol infusion. J Cardiovasc Electrophysiol. Xxx (in press).
10. Rostock T, O’Neill MD, Sanders P, Rotter M, Jais P, Hocini M,
Takahashi Y, Sacher F, Jönsson A, Hsu LF, Clementy J, Haissaguerre M.
Characterization of conduction recovery across left atrial linear
lesions in patients with paroxysmal and persistent atrial fibrillation.
J Cardiovasc Electrophysiol. 2006;17:1106-1111.
11. Chen J, Arentz T, Cochet H, Müller-Edenborn B, Kim S,
Moreno-Weidmann Z, Minners J, Kohl P, Lehrmann H, Allgeier J, Trenk D,
Hocini M, Jais P, Haissaguerre M, Jadidi A. Extent and spatial
distribution of left atrial arrhythmogenic sites, late gadolinium
enhancement at magnetic resonance imaging, and low-voltage areas in
patients with persistent atrial fibrillation: comparison of imaging vs.
electrical parameters of fibrosis and arrhythmogenesis. Europace.
2019;21:1484-1493.
12. Takagi T, Derval N, Pambrun T, Nakatani Y, Andre C, Ramirez FD,
Nakashima T, Krisai P, Kamakura T, Pineau X, Tixier R, Chauvel R,
Cheniti G, Duchateau J, Sacher F, Hocini M, Haissaguerre M, Jais P,
Cochet H. Optimized computed tomography acquisition protocol for ethanol
infusion into the vein of Marshall. JACC Clin Electrophysiol.
2022;8:168-178.